HCP Hohaus Advisory
HCP Hohaus Advisory launched its first product to the market November 25, 2016 and a second one August 27, 2017.
Please email us at
to learn more or continue reading below.
Please click on 'Agree' to agree to the following disclaimer
Access restrictions to the investment products pages
You acknowledge that you are aware of the fact that the distribution to the public of investment products presented on the Investment Products pages is authorised only in certain countries as described in the prospectus.
Consequently, in respect of any person or entity subject to any other jurisdiction than those mentioned in the prospectus the Investment Products pages do not constitute either an offer to sell or a solicitation to buy investment products. In other words, the information published on the Investment Products pages is addressed solely to persons resident and businesses domiciled in the countries mentioned in the prospectus. By accepting the Terms and conditions relating to investment products, you declare that you are resident or domiciled in those countries. If you are not resident or domiciled in the countries listed in the prospectus, you are not authorised to access the Investment Products pages. Furthermore, the Investment Products pages are not addressed to U.S. Persons. By accepting these Terms and Conditions, you declare that you are not a U.S. Person. If you are a U.S. Person, you are not authorised to access the Investment Products pages.
Terms and Conditions
By accessing the information provided by HCP Hohaus Advisory on its website (hereafter website), you agree to the following rules:
Copyright and use of HCP Hohaus Advisory’s website
The whole content of HCP Hohaus Advisory’s website is subject to copyright (all rights reserved). You are allowed to download and print documents and/or pages from the website, by committing not to delete any references to HCP Hohaus Advisory. Any reproduction or use of the website information or content for public or commercial purposes without prior written consent of HCP Hohaus Advisory is prohibited. This includes also our brand name "HCP" and the logo, a stylizied world plus the letters "HCP".
No Offer or Advice
The information contained in the web site is provided for information purposes only and should in no event be construed as a solicitation or offer, as advice or as a recommendation to buy, sell or engage in any transaction whatsoever. The information included on the web site does not constitute a prospectus within the meaning of Art. 652a and/or Art. 1156 of the Swiss Code of Obligations or Art. 32 ff. of the Swiss Listing Rules. None of the services, investment products or mutual funds referred to in the site is available, and prospectuses in respect of them will not be distributed to persons resident in any state or territory where such distribution would be contradictory to local law or regulation.
Prior to making any investment decision, the investor should fully understand the economic risks and merits, as well as the legal, tax and accounting characteristics and consequences of the transaction, and make his own determination that the investment is consistent with his objectives and that he is able to assume the risk. Prior to entering into any transaction, investors are advised to engage their own legal, tax and accounting professionals where they deem necessary. Any decisions taken with regard to investments are based exclusively on the personal assessment of the investor.
Potential investors should note that investments can involve significant risks and the value of an investment may go down as well as up. No assurance can be given that the investment objective of any product will be achieved or that substantial losses will not be suffered. There is no guarantee of trading performance and past or projected performance is not necessarily a guide to future results.
2016-2019 HCP Hohaus Advisory